WO2024218800 - VAGINAL DRUG DELIVERY SYSTEM OF DYDROGESTERONE
National phase entry is expected:
Publication Number
WO/2024/218800
Publication Date
24.10.2024
International Application No.
PCT/IN2024/050419
International Filing Date
21.04.2024
Title **
[English]
VAGINAL DRUG DELIVERY SYSTEM OF DYDROGESTERONE
[French]
SYSTÈME D'ADMINISTRATION DE MÉDICAMENT VAGINAL DE DYDROGESTÉRONE
Applicants **
AKUMS DRUGS AND PHARMACEUTICALS LIMITED
Inventors
JAIN, Sanjeev
JAISWAL, Sunil
AGGARWAL, Ajeet Kumar
KUMAR, Dinesh
PAL, Vikas
YADAV, Dinesh kumar
PATHAK, Alok Kumar
Priority Data
202311029401
21.04.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1977 | |
| EPO | Filing, Examination, Granting | 11254 | |
| Japan | Filing, Examination, Granting | 2083 | |
| South Korea | Filing, Examination, Granting | 1848 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
23,102
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides a novel drug delivery system comprising Dydrogesterone to overcome the problems associated with conventional drug delivery system. The novel drug delivery system of present invention provides a vaginal formulation for effective treatment of female associated reproductive cycle disorders. The vaginal formulation of present invention comprises Dydrogesterone and pharmaceutical acceptable excipients and provides process of preparation thereof.[French]
La présente invention concerne un nouveau système d'administration de médicament comprenant de la dydrogestérone pour surmonter les problèmes associés au système d'administration de médicament classique. Le nouveau système d'administration de médicament de la présente invention fournit une formulation vaginale pour le traitement efficace de troubles du cycle de la reproduction associés chez la femme. La formulation vaginale de la présente invention comprend de la dydrogesterone et des excipients pharmaceutiquement acceptables et fournit un procédé de préparation de celle-ci.